JP2017520547A5 - - Google Patents

Download PDF

Info

Publication number
JP2017520547A5
JP2017520547A5 JP2016572800A JP2016572800A JP2017520547A5 JP 2017520547 A5 JP2017520547 A5 JP 2017520547A5 JP 2016572800 A JP2016572800 A JP 2016572800A JP 2016572800 A JP2016572800 A JP 2016572800A JP 2017520547 A5 JP2017520547 A5 JP 2017520547A5
Authority
JP
Japan
Prior art keywords
formula
compound
hydrogen
alkyl
defined above
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016572800A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017520547A (ja
JP6785666B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2015/063942 external-priority patent/WO2015197534A2/en
Publication of JP2017520547A publication Critical patent/JP2017520547A/ja
Publication of JP2017520547A5 publication Critical patent/JP2017520547A5/ja
Application granted granted Critical
Publication of JP6785666B2 publication Critical patent/JP6785666B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016572800A 2014-06-23 2015-06-22 1,3−ベンゾジオキソール複素環化合物の調製方法 Active JP6785666B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14173397.2 2014-06-23
EP14173397 2014-06-23
PCT/EP2015/063942 WO2015197534A2 (en) 2014-06-23 2015-06-22 Methods for the preparation of 1,3-benzodioxole heterocyclic compounds

Publications (3)

Publication Number Publication Date
JP2017520547A JP2017520547A (ja) 2017-07-27
JP2017520547A5 true JP2017520547A5 (enExample) 2018-07-26
JP6785666B2 JP6785666B2 (ja) 2020-11-18

Family

ID=50980952

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016572800A Active JP6785666B2 (ja) 2014-06-23 2015-06-22 1,3−ベンゾジオキソール複素環化合物の調製方法

Country Status (18)

Country Link
US (1) US9908894B2 (enExample)
EP (1) EP3157930B1 (enExample)
JP (1) JP6785666B2 (enExample)
KR (1) KR20170016894A (enExample)
CN (1) CN106459081B (enExample)
AU (1) AU2015279428B2 (enExample)
BR (1) BR112016029510A2 (enExample)
CA (1) CA2953284A1 (enExample)
DK (1) DK3157930T3 (enExample)
ES (1) ES2702451T3 (enExample)
IL (1) IL249336A0 (enExample)
MX (1) MX2016016378A (enExample)
PL (1) PL3157930T3 (enExample)
PT (1) PT3157930T (enExample)
RU (1) RU2697251C2 (enExample)
TW (1) TW201613934A (enExample)
WO (1) WO2015197534A2 (enExample)
ZA (1) ZA201608442B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX385592B (es) * 2015-12-18 2025-03-18 Union Therapeutics As Metodos para preparacion de compuestos heterociclicos de 1,3-benzodioxol.
CA3064033A1 (en) * 2017-06-20 2018-12-27 Leo Pharma A/S Methods for the preparation of 1,3-benzodioxole heterocyclic compounds
DK3724196T3 (da) 2017-12-15 2023-01-16 Union Therapeutics As Substituerede azetidindihydrothienopyridiner og anvendelse deraf som phosphodiesterasehæmmere
USD914676S1 (en) 2018-05-11 2021-03-30 Samsung Electronics Co., Ltd. Notebook computer
NZ778223A (en) 2019-01-15 2024-11-29 Union Therapeutics As Modified release tablet formulations containing phosphodiesterase inhibitors
AU2022245186A1 (en) 2021-03-22 2023-10-05 UNION therapeutics A/S Treatment of hidradenitis suppurativa with orismilast
GB202205715D0 (en) 2022-04-19 2022-06-01 Union Therapeutics As Treatment of neutrophilic dermatoses
GB202306662D0 (en) 2023-05-05 2023-06-21 Union Therapeutics As Dosage regimen
GB202306663D0 (en) 2023-05-05 2023-06-21 Union Therapeutics As Combination therapy

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6514996B2 (en) * 1995-05-19 2003-02-04 Kyowa Hakko Kogyo Co., Ltd. Derivatives of benzofuran or benzodioxole
ATE325110T1 (de) * 1995-05-19 2006-06-15 Kyowa Hakko Kogyo Kk Sauerstoff enthaltende heterocyclische verbindungen
DE10205274A1 (de) * 2002-02-08 2003-08-21 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen enthaltend neben Anticholinergika heterocyclische Verbindungen
JPWO2004005276A1 (ja) * 2002-07-03 2005-11-04 協和醗酵工業株式会社 1,3−ベンゾジオキソール−2−スピロシクロアルカン誘導体の製造法
ATE496029T1 (de) * 2006-07-14 2011-02-15 Chiesi Farma Spa Derivate von 1-phenyl-2-pyridinylalkylenalkohole als phosphodiesteraseinhibitoren
DK2125736T3 (da) * 2006-12-22 2011-07-11 Leo Pharma As Substituerede acetophenoner egnede som PDE4-inhibitorer
PL2114951T3 (pl) * 2007-02-28 2014-10-31 Leo Pharma As Nowe inhibitory fosfodiesterazy
ZA200905371B (en) * 2007-02-28 2010-10-27 Leo Pharma As Novel phosphodiesterase Inhibitors
ES2733092T3 (es) * 2010-06-24 2019-11-27 Leo Pharma As Derivados de benzodioxol como inhibidores de la fosfodiesterasa
WO2014096018A1 (en) * 2012-12-19 2014-06-26 Leo Pharma A/S Methods for the preparation of substituted acetophenones
MX385592B (es) * 2015-12-18 2025-03-18 Union Therapeutics As Metodos para preparacion de compuestos heterociclicos de 1,3-benzodioxol.

Similar Documents

Publication Publication Date Title
JP2017520547A5 (enExample)
RU2017101808A (ru) Способы получения 1, 3-бензодиоксольных гетероциклических соединений
JP2025084856A5 (enExample)
JP2018193405A5 (enExample)
JP2015524406A5 (enExample)
JP2018529687A5 (enExample)
JP2017522357A5 (enExample)
JP2017501197A5 (enExample)
JP2015536898A5 (enExample)
JP2017505801A5 (enExample)
US10167246B2 (en) Preparative method for carboxylic acids
CN104803956A (zh) 非罗考昔的一种合成方法
JP2018507858A5 (enExample)
JP2012251113A5 (enExample)
JP2018528948A5 (enExample)
JP2021046426A5 (enExample)
JP2017533926A5 (enExample)
JP2013525317A5 (enExample)
JP2013064130A5 (enExample)
JP2019521165A5 (enExample)
CN102351621B (zh) 一种n-砜基脒的制备方法
JP2017517513A5 (enExample)
JP2016515555A5 (enExample)
CN105037319B (zh) 金催化的分子内重氮偶联选择性生成反式大环烯烃的方法
CN103073492A (zh) 2-[3-(s)-[3-[2-(7-氯-2-喹啉基)乙烯基]苯基]-3-羟基丙基]苯甲酸酯的合成方法